ICL executive reports stock option holdings

ICL Group Ltd. executive Meshulam Amir, SVP Global Internal Audit, reported his initial ownership of stock options in a Form 3 filing.

Accepted by SEC EDGAR 03/30/2026 - 06:23 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ICL Group Ltd. executive Meshulam Amir, SVP Global Internal Audit, reported his initial ownership of stock options in a Form 3 filing. He holds fully vested options over 206,557 Ordinary Shares with a $9.39 exercise price, expiring on February 8, 2027. He also holds options over 275,547 Ordinary Shares at a $5.87 exercise price, expiring on April 4, 2029, which vest in three equal annual installments starting from April 4, 2025. The options are held by a trustee in his name, and this filing reflects holdings rather than new purchases or sales.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Meshulam Amir

Role SVP, Global Internal Audit

Type	Security	Shares	Price	Value
Holding	Stock Options (Right to Buy)	--	--	--
Holding	Stock Options (Right to Buy)	--	--	--

Holdings: Stock Options (Right to Buy) — 482,104 contracts (Direct)

Footnotes (5)

1. F1. The stock options are fully vested and exercisable.
2. F2. The stock options vest in three equal annual installments from the April 4, 2025, grant date.
3. F3. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
4. F4. The options are held by a Trustee in the name of the Reporting Person.
5. F5. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

Key Figures

Option grant 1 underlying shares: 206,557 shares Option grant 1 exercise price: $9.39 per share Option grant 2 underlying shares: 275,547 shares +5 more

8 metrics

Option grant 1 underlying shares 206,557 shares Ordinary Shares underlying fully vested options at $9.39 exercise price

Option grant 1 exercise price $9.39 per share Exercise price for options expiring February 8, 2027

Option grant 2 underlying shares 275,547 shares Ordinary Shares underlying options at $5.87 exercise price

Option grant 2 exercise price $5.87 per share Exercise price for options expiring April 4, 2029

Vesting schedule 3 equal annual installments Vesting pattern from April 4, 2025 grant date

NIS exercise price 1 NIS 29.57 Local-currency exercise price converted using $1.00 = NIS 3.149

NIS exercise price 2 NIS 18.47 Second local-currency exercise price using same $1.00 = NIS 3.149 rate

Exchange rate used $1.00 = NIS 3.149 Bank of Israel representative exchange rate as of March 27, 2026

Key Terms

Stock Options (Right to Buy), Ordinary Shares, fully vested and exercisable, three equal annual installments, +2 more

6 terms

Stock Options (Right to Buy) financial

"security_title: Stock Options (Right to Buy)"

Ordinary Shares financial

"underlying_security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

fully vested and exercisable financial

"The stock options are fully vested and exercisable."

three equal annual installments financial

"The stock options vest in three equal annual installments from the April 4, 2025, grant date."

Bank of Israel representative exchange rate financial

"converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149"

Trustee financial

"The options are held by a Trustee in the name of the Reporting Person."

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ICL Form 3 filed by Meshulam Amir report?

The Form 3 reports SVP Global Internal Audit Meshulam Amir’s initial ownership of stock options in ICL Group Ltd.. It lists two option grants over ordinary shares, including exercise prices, expiration dates, and vesting terms, without showing any recent option exercises or share sales.

How many ICL stock options does Meshulam Amir hold according to the Form 3?

According to the filing, Meshulam Amir holds options over 206,557 Ordinary Shares at $9.39 per share and options over 275,547 Ordinary Shares at $5.87 per share. These totals represent his reported derivative positions, not currently exercised shares of ICL common stock.

What are the exercise prices and expirations of Amir’s ICL stock options?

One ICL option grant has a $9.39 exercise price and expires on February 8, 2027. The other grant has a $5.87 exercise price and expires on April 4, 2029. These figures indicate the prices and timeframes for potentially converting options into ordinary shares.

How do the vesting terms work for Amir’s ICL stock options?

The filing notes one set of options is fully vested and exercisable. The other set vests in three equal annual installments beginning on April 4, 2025. This means those options become exercisable gradually over three years from the stated grant date.

Are Meshulam Amir’s ICL options held directly or through a trustee?

The Form 3 states the options are held by a Trustee in the name of the Reporting Person. Economically they are attributed to Amir, but the trustee is the formal holder. This structure is common in employee equity plans, especially where local regulations encourage trustee arrangements.

Does the ICL Form 3 show any recent buying or selling by Meshulam Amir?

No, the Form 3 functions as an initial ownership report and lists existing stock option holdings. The transaction summary shows no buys or sells and classifies entries as holdings, indicating there were no new market purchases, sales, or option exercises reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Meshulam Amir

(Last) (First) (Middle)

C/O ICL GROUP LTD

MILLENNIUM TOWER, 23 ARENHA ST.

(Street)

TEL AVIV 6120201

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ICL Group Ltd. [ ICL ]

3a. Foreign Trading Symbol
[ICL]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Global Internal Audit

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(1)	02/08/2027	Ordinary Shares	206,557	$9.39(3)	D(4)
Stock Options (Right to Buy)	(2)	04/04/2029	Ordinary Shares	275,547	$5.87(5)	D(4)

Explanation of Responses:

1. The stock options are fully vested and exercisable.

2. The stock options vest in three equal annual installments from the April 4, 2025, grant date.

3. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

4. The options are held by a Trustee in the name of the Reporting Person.

5. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

	/s/ Meshulam Amir	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)